Evidence map›Paper›PMID 41782652›Full record

ArticleHealth science reports2026

Global Burden of Lead Exposure: Integrating Epidemiology, Molecular Mechanisms, and Mitigation Approaches.

Gudisa Bereda

Abstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gudisa BeredaDepartment of Pharmacy Marie Stopes International (MSIE) Ambo Ethiopia.ORCID https://orcid.org/0000-0002-5982-9601

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lead is a nonessential, toxic heavy metal that causes widespread environmental contamination, affecting humans, animals, plants, and ecosystems. Globally, an estimated 800 million children have blood lead levels (BLLs) above 5 µg/dL. Lead persists in the environment and accumulates in the body, particularly in bone, due to its chemical similarity to calcium. Objectives: This review aimed to summarize the prevalence, environmental sources, molecular and cellular mechanisms, dose-dependent toxic effects, and mitigation strategies related to lead exposure. Methods: A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Google Scholar to identify relevant studies published between 2010 and 2025. Both peer-reviewed and gray literature were qualitatively synthesized. Results: The findings indicated that lead exposure is pervasive, with detectable levels in 100% of participants in EU biomonitoring studies. In the United States, ~590,000 children under 5 years of age had BLLs above 3.5 µg/dL. Lead disrupts essential metal homeostasis, induces oxidative stress, causes mitochondrial dysfunction, disrupts calcium signaling, impairs heme synthesis, and triggers DNA damage, endoplasmic reticulum stress, cell membrane injury, and impaired signal transduction. Experimental studies in mice and chickens demonstrated dose-dependent accumulation in blood, tissues, and organs, accompanied by significant decreases in Zn, Fe, Mg, and Ca levels and elevated oxidative stress markers. Effective mitigation strategies include regulatory policies, environmental remediation, occupational safety measures, public health education, maternal and child health interventions, food and water safety measures, technological innovations, and continuous monitoring. Conclusion: This review showed that lead remains a significant public health threat and underscores the need for targeted and equity-focused interventions.

Indexed as

blood lead levelsenvironmental contaminationepidemiologylead exposuremitigation strategiesmolecular mechanismsoxidative stress

Identifiers

PMID41782652
PMCPMC12953182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.